Pivotal Clinical SAHARA Study Shows Candesant Biomedical's Investigational Sweat Control Patch Significantly Reduces Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)
/PRNewswire/ -- Candesant Biomedical ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive...
United States Eastern Virginia Medical School New Orleans Suzanne Haber David Pariser Virginia Clinical Research Inc
Source: prnewswire.com